Schoeneck James A — SEC Form 4 filings
SEC reporting owner CIK 1420987. 13 Form 4 filings on record with FilingPulse; latest filed 2026-08-19.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-04-22 to 2026-08-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 3 filings — 398,567 shares, $374,525 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: purchase of 75,000 shares @ $2.00 ($150,000) in Calidi Biotherapeutics, Inc., filed 2025-08-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| KYNTRA BIO, INC. (KYNB) | Director | 5 | 3 legs · 323,567 sh · $224,525 | — | 3 |
| Calidi Biotherapeutics, Inc. (CLDI) | Director | 8 | 1 leg · 75,000 sh · $150,000 | — | 17 |
Form 4 filings — Schoeneck James A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-19 | 4 | Calidi Biotherapeutics, Inc. (CLDI) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | KYNTRA BIO, INC. (KYNB) | Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2025-08-25 | 4 | Calidi Biotherapeutics, Inc. (CLDI) | Purchase (P): 75,000 @ $2 · Purchase (P): 75,000 (derivative) | EDGAR |
| 2025-07-15 | 4 | Calidi Biotherapeutics, Inc. (CLDI) | Grant/award (A): 164,493 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | FIBROGEN INC (FGEN) | Purchase (P): 23,567 @ $5.07 | EDGAR |
| 2025-06-06 | 4 | FIBROGEN INC (FGEN) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | FIBROGEN INC (FGEN) | Purchase (P): 250,000 @ $0.35 · Purchase (P): 50,000 @ $0.34 | EDGAR |
| 2024-10-15 | 4 | Calidi Biotherapeutics, Inc. (CLDI) | Grant/award (A): 20,217 (derivative) | EDGAR |
| 2024-07-02 | 4 | Calidi Biotherapeutics, Inc. (CLDI) | Grant/award (A): 28,207 | EDGAR |
| 2024-07-02 | 4 | Calidi Biotherapeutics, Inc. (CLDI) | Grant/award (A): 79,687 | EDGAR |
| 2024-06-06 | 4 | FIBROGEN INC (FGEN) | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Calidi Biotherapeutics, Inc. (CLDI) | Option exercise (M): 173,000 @ $0.20 · Option exercise (M): 375,000 @ $0.20 · Option exercise (M): 173,000 (derivative) · Option exercise (M): 173,000 (derivative) · Option exercise (M): 375,000 (derivative) · Option exercise (M): 375,000 (derivative) · +1 more | EDGAR |
| 2024-04-22 | 4 | Calidi Biotherapeutics, Inc. (CLDI) | Grant/award (A): 375,000 @ $0.40 · Grant/award (A): 375,000 (derivative) · Grant/award (A): 375,000 (derivative) · Grant/award (A): 375,000 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1420987 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →